NEW YORK, Oct. 10, 2023 – PRESS RELEASE – Curaleaf Holdings Inc., a leading international provider of consumer products in cannabis, announced that it has filed its application to list the company's subordinate voting shares on the Toronto Stock Exchange (TSX).
As previously announced, the company completed a marketed offering of subordinate voting shares on Oct. 3, 2023, in order to satisfy a condition required for a potential listing on the TSX.
"We are pleased to announce we have submitted our listing application to the TSX," Executive Chairman Boris Jordan said. "I believe uplisting to the TSX will provide greater access to a broader set of global institutional investors, offer custody solutions backed by U.S. financial institutions, reduce volatility in our stock by having dedicated market makers, and make Curaleaf available for inclusion into indexes such as TSX and MSCI, all to the benefit of our stakeholders. We continually manage the business with the best interest of the company in mind, and filing our application with the TSX is yet another step in that direction."
The listing of the subordinate voting shares on the TSX remains subject to the review of the TSX and is contingent on the satisfaction of all listing and regulatory requirements. There is no assurance that the TSX will approve the listing application or that the company will complete the listing on the TSX as currently proposed.
